Last reviewed · How we verify

NCT05740241: UNITS-APA

Use of New Tools to Estimate the Intensity of Adapted Physical Activity Sessions

Completed Last updated 26 June 2025
What this trial tests

trial testing Elderly in Ageing in 87 participants. Completed in 23 May 2025.

Timeline
5 February 2024
Primary endpoint
5 May 2025
23 May 2025

Quick facts

Lead sponsorCentre Hospitalier Universitaire de Nice
StatusCompleted
Study typeOBSERVATIONAL
Enrollment87
Start date5 February 2024
Primary completion5 May 2025
Estimated completion23 May 2025
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Centre Hospitalier Universitaire de Nice

Who can join

65 and older, any sex, with Ageing. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In the field of sport/health, the prescription is generic and individualisation, which is still very rare, is generally linked only to physical performance. These limitations on the implementation of the sessions will result in limiting the effects of the training programme and increasing the risk of injury. It is therefore necessary to develop knowledge and tools to assist physicians and physical activity professionals in their decision making. The aim of the study is to improve the precision of the calculation of the training load in order to better individualise the management of the participants.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Ageing

Currently open trials in the same condition.

Other Centre Hospitalier Universitaire de Nice trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05740241.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing